New research suggests that hypertension and diabetes and the use of medications to treat these conditions may influence the survival of ovarian cancer patients.
Carole McCue, MS, RN, CNE
Advertisement
Articles by Carole McCue, MS, RN, CNE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC
3
Neoadjuvant Strategies and Early Biomarker Testing in EGFR-Mutated NSCLC
4
Nadofaragene Firadenovec Label Update Approved in BCG-Unresponsive NMIBC
5